Oxford Sciences Innovation spin out Ultromics has raised £10m ( £10m ) in a series A round, led by Ultromics . Ultromics has developed echocardiography analysis technology that aims to significantly increase accuracy in diagnosing coronary artery disease, reducing diagnostic errors by 75% . The technology is currently being trialled at six UK National Health Service hospitals and is to be expanded to 20 hospitals by 2019 . The funds will be used to bring the technology to market in the UK , roll out in the UK early in 2019 and for further R&D.
Oxford University spin out Ultromics has raised £10m ($13.3m) in a series A round, led by Oxford Sciences Innovation. Ultromics has developed echocardiography analysis technology that aims to significantly increase accuracy in diagnosing coronary artery disease, reducing diagnostic errors by 75%. The technology is currently being trialled at six UK National Health Service hospitals and is to be expanded to 20 hospitals by year end. The funds will be used to bring the technology to market in the US, roll out in the UK early in 2019 and for further R&D.